R
Robert Falotico
Researcher at Cordis
Publications - 84
Citations - 9999
Robert Falotico is an academic researcher from Cordis. The author has contributed to research in topics: Stent & Restenosis. The author has an hindex of 28, co-authored 84 publications receiving 9856 citations. Previous affiliations of Robert Falotico include Johnson & Johnson.
Papers
More filters
Journal ArticleDOI
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
Marie-Claude Morice,Patrick W. Serruys,J. Eduardo Sousa,Jean Fajadet,Ernesto Ban Hayashi,Marco Antonio Perin,Antonio Colombo,Gerhard Schuler,Paul Barragan,Giulio Guagliumi,Ferenc Molnar,Robert Falotico +11 more
TL;DR: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Journal ArticleDOI
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Andrea Abizaid,Fausto Feres,Ibraim Francisco Pinto,Ana C. Seixas,Rodolfo Staico,Luiz Alberto Mattos,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: In this article, the safety and efficacy of sirolimus-coated BX Velocity stents were evaluated in 30 patients with angina pectoris electively treated with two different formulations of SIROlimuscoated stents (slow release and fast release).
Journal ArticleDOI
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
Takeshi Suzuki,Greg Kopia,Shin Ichiro Hayashi,Lynn Bailey,Gerard H. Llanos,Robert L. Wilensky,Bruce D. Klugherz,George Papandreou,Pallassana Narayan,Martin B. Leon,Alan C. Yeung,Fermin O. Tio,Philip S. Tsao,Robert Falotico,Andrew J. Carter +14 more
TL;DR: Stent-based delivery of SRL via a nonerodable polymer matrix is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation.
Journal ArticleDOI
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents One-Year Angiographic and Intravascular Ultrasound Follow-Up
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Benno J. Rensing,Andrea Abizaid,Luiz Fernando Tanajura,Ken Kozuma,Glenn Van Langenhove,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +12 more
TL;DR: This study demonstrates a sustained suppression of neointimal proliferation by sirolimus-eluting Bx VELOCITY stents 1 year after implantation.
Patent
Extraction of solvents from drug containing polymer reservoirs
TL;DR: In this article, a process for reducing solvent contents in drug-containing polymeric compositions may be utilized to reduce the solvent content in implantable medical device wherein the compositions are in reservoirs.